ZIOPHARM ONCOLOGY INC of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-28. The offering totals $57.5M, of which $57.5M was reported sold. Industry: Biotechnology.
Showing 25 of 45 people.
| Name | Role | Location |
|---|---|---|
| Wyche Fowler | Director | Boston, MA |
| Randal Kirk | Director | Boston, MA |
| JONATHAN LEWIS | Director | Oklahoma City, OK |
| Timothy McInerney | Director | New York, NY |
| Kevin Lafond | Executive Officer | Boston, MA |
| JONATHAN LEWIS | Executive Officer | Oklahoma City, OK |
| Douglas W Pagan | Director | Boston, MA |
| Scott G Braunstein | Director | Cambridge, MA |
| Sath M Shukla | Executive Officer | Boston, MA |
| Heidi M Hagen | Director | Boston, MA |
| Scott M Braunstein | Director | Boston, MA |
| Elan Z Ezickson | Director | Boston, MA |
| Scott W Tarriff | Director | Boston, MA |
| Eleanor M De Groot | Executive Officer | Boston, MA |
| Robert G Hadfield | Executive Officer | Boston, MA |
| David M Mauney | Executive Officer | Boston, MA |
| Kevin G Lafond | Executive Officer | Boston, MA |
| Laurence JN Cooper | Director | Boston, MA |
| Laurence JN Cooper | Executive Officer | Boston, MA |
| Jill M Buck | Executive Officer | Boston, MA |
| James Cannon | Director | Austin, TX |
| Robert W Hadfield | Executive Officer | Boston, MA |
| David W Mauney | Executive Officer | Boston, MA |
| James A Cannon | Director | Boston, MA |
| Scott JN Tarriff | Director | Boston, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2019-09-17 | D | $19.5M | $19.5M |
| 2019-08-09 | D | $105.1M | $105.1M |
| 2018-11-19 | D | $107.0M | $50.0M |
| 2016-07-07 | D | $120.0M | $120.0M |
| 2012-11-21 | D | $4K | $4K |
| 2011-01-14 | D | $11.6M | $11.6M |
| 2009-09-29 | D | $5.1M | $5.1M |